"Avian Sarcoma Viruses" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Group of alpharetroviruses (ALPHARETROVIRUS) producing sarcomata and other tumors in chickens and other fowl and also in pigeons, ducks, and RATS.
| Descriptor ID |
D001358
|
| MeSH Number(s) |
B04.613.807.070.120 B04.820.650.070.120
|
| Concept/Terms |
Avian Sarcoma Viruses- Avian Sarcoma Viruses
- Avian Sarcoma Virus
- Sarcoma Virus, Avian
- Virus, Avian Sarcoma
- Viruses, Avian Sarcoma
- Sarcoma Viruses, Avian
Fujinami sarcoma virus- Fujinami sarcoma virus
- Fujinami sarcoma viruses
- sarcoma virus, Fujinami
- virus, Fujinami sarcoma
- viruses, Fujinami sarcoma
|
Below are MeSH descriptors whose meaning is more general than "Avian Sarcoma Viruses".
Below are MeSH descriptors whose meaning is more specific than "Avian Sarcoma Viruses".
This graph shows the total number of publications written about "Avian Sarcoma Viruses" by people in this website by year, and whether "Avian Sarcoma Viruses" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 2 | 2 |
| 1997 | 2 | 1 | 3 |
| 1998 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 1 | 2 |
| 2002 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2006 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Avian Sarcoma Viruses" by people in Profiles.
-
Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models. Proc Natl Acad Sci U S A. 2006 Nov 14; 103(46):17396-401.
-
The negative regulator of splicing element of Rous sarcoma virus promotes polyadenylation. J Virol. 2006 Oct; 80(19):9634-40.
-
Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patients. Int J Radiat Oncol Biol Phys. 2004 Jun 01; 59(2):562-71.
-
High and selective expression of yeast cytosine deaminase under a carcinoembryonic antigen promoter-enhancer. Cancer Res. 2002 Apr 15; 62(8):2337-42.
-
Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters. Prostate Cancer Prostatic Dis. 2002; 5(4):316-25.
-
Adenovirus-mediated suicide gene therapy for bladder cancer: comparison of the cytomegalovirus- and Rous sarcoma virus-promoter. Anticancer Res. 2000 Sep-Oct; 20(5A):2811-6.
-
Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors. Mol Ther. 2000 Feb; 1(2):195-203.
-
Comparison of long-term survival of cytomegalovirus promotre versus Rous Sarcoma virus promoter-driven thymidine kinase gene therapy in nude mice bearing human ovarian cancer. Hybridoma. 1999 Feb; 18(1):93-7.
-
Identification of v-Rel oncogene-induced inhibitor of apoptosis by differential display. Methods. 1998 Dec; 16(4):373-85.
-
Adenovirus mediated thymidine kinase gene therapy may enhance sensitivity of ovarian cancer cells to chemotherapeutic agents. Anticancer Res. 1998 Sep-Oct; 18(5A):3421-6.